Publication date: Available online 2 November 2018
Source: Ultrasound in Medicine & Biology
Author(s): Kelsey M. Wasilczuk, Kelsey C. Bayer, Jesse P. Somann, Gabriel O. Albors, Jennifer Sturgis, L. Tiffany Lyle, J. Paul Robinson, Pedro P. Irazoqui
Abstract
Tumor necrosis factor α (TNF-α) is linked to several chronic inflammatory diseases. Electrical vagus nerve stimulation reduces serum TNF-α levels but may cause chronic nerve damage and requires surgery. Alternatively, we proposed focused ultrasound stimulation of the vagus nerve (uVNS), which can be applied non-invasively. In this study, we induced an inflammatory response in rats using lipopolysaccharides (LPS) and collected blood to analyze the effects of uVNS on cytokine concentrations. We applied one or three 5-min pulsed focused ultrasound stimulation treatments to the vagus nerve (250 kHz, ISPPA = 3 W/cm2). Animals receiving a single ultrasound application had an average reduction in TNF-α levels of 19%, similar to the 16% reduction observed in electrically stimulated animals. With multiple applications, uVNS therapy statistically reduced serum TNF-α levels by 73% compared with control animals without any observed damage to the nerve. These findings suggest that uVNS is a suitable way to attenuate TNF-α levels.
from Imaging via a.sfakia on Inoreader https://ift.tt/2ALIDNb
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.